Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Nanologica AB (publ)
AB
Active
Org 5566645023
Forskargatan 20 G, 151 36
Södertälje
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2004
20-49 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Nanologica AB (publ)
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
5M
9M
14M
18M
16M
2020
13M
2021
2M
2022
1M
2023
15M
2024
EBITDA
SEK millions
0M
-5M
-9M
-14M
-18M
-16M
2020
-33M
2021
-42M
2022
-54M
2023
-46M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
16 135
12 914
1 555
1 443
14 538
Staff expenses
—
—
—
—
—
EBITDA
−15 881
−32 830
−41 987
−53 599
−46 384
Depreciation & amort.
−6 272
−9 245
−9 497
−17 000
−13 384
EBIT
−22 153
−42 075
−51 484
−70 599
−59 768
Net financials
−2 637
−8 021
−4 349
−5 281
−6 631
Profit before tax
−24 788
−46 225
−55 788
−75 880
−66 008
Tax
−0
−0
−0
−0
−0
Net profit
−24 788
−46 225
−55 788
−75 880
−66 008
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
137 404
88 413
146 788
71 678
134 450
Equity
90 601
47 834
68 840
−6 940
68 641
Long-term debt
30 693
28 333
66 601
66 757
0
Short-term debt
15 592
11 716
10 774
11 290
65 809
Total debt
46 285
40 049
77 375
78 047
65 809
Financial ratios
5-year trend
EBITDA margin
-319.1%
This company
15.8%
Market median
-2120% vs market
2020
2024
Equity ratio
51.1%
This company
38.2%
Market median
+34% vs market
2020
2024
Return on equity
-96.2%
This company
18.4%
Market median
-623% vs market
2020
2024
Net profit margin
-454.0%
This company
8.1%
Market median
-5705% vs market
2020
2024
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
2020
2024
Debt / equity
0.96×
This company
0.62×
Market median
+55% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Nanologica AB (publ)
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
